If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
55.00    1.70 (3.19%)
Bid:
54.70
Ask:
55.10
Spread: 0.40 (0.731%)
Market Cap: £348.12m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Financial Waiver and Reopening Update

7 Apr 2021 07:00

RNS Number : 5718U
Marston's PLC
07 April 2021
 

 

7 April 2021

 

MARSTON'S PLC

("Marston's" or "the Group")

 

Financial Waiver and Reopening Update

Marston's PLC provides the following update in respect of financial covenant waivers and reopening plans following the recent Government announcements.

Financial Covenant Waivers

Further to the statement issued on 26 March 2021, the Group can now confirm that it has secured waivers and amendments to its Bank, Private Placement and Securitised facilities for the financial periods up to and including 1 January 2022.

 

Within the securitisation, Marston's had strong support from bondholders who have approved waivers for the two-quarter tests to 2 October 2021 and the four-quarter test to 1 January 2022. The Group's banks and private placement have approved the adoption of liquidity and quarterly profit covenants to 1 January 2022.

 

This collaborative approach was helped by open and constructive dialogue in a period of great uncertainty and underlines the importance of good, long-term relationships with all our stakeholders.

 

Reopening Plans

 

The Group expects to reopen around 70% (c.700) of its managed and franchised pubs in England with outdoor spaces on or around 12 April and, subject to final regulatory confirmation, the majority of our Scottish and Welsh pubs on 26 April.

 

On the basis that the stated reopening roadmap set out by the Government is adhered to, the remaining managed estate in England should open on or around 17 May with restricted indoor trading, and we are assuming a return to normal trading conditions from 21 June.

 

The Group will announce its Interim Results for the 26 weeks ended 3 April 2021 on 19 May 2021.

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2010/2005

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood

 

NOTES TO EDITORS

· Marston's is a leading pub operator with a 40% holding in Carlsberg Marston's Brewing Company

· It operates an estate of around 1,500 pubs situated nationally, comprising managed, franchised and leased pubs

· Marston's employs around 11,000 people

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDIFMFTMTMMBRB
Date   Source Headline
3rd Jul 20268:43 amRNSDirector/PDMR Shareholding
1st Jul 202612:27 pmRNSTotal Voting Rights
22nd Jun 20263:44 pmRNSHolding(s) in Company
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.